Immunome to Present at 2024 Bank of America Healthcare Conference
2024年5月8日 - 9:00PM
ビジネスワイヤ(英語)
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused
on developing first-in-class and best-in-class targeted cancer
therapies, today announced that Clay Siegall, PhD, President and
Chief Executive Officer, will present at the 2024 Bank of America
Healthcare Conference on Wednesday, May 15, 2024 at 10:40 A.M.
Pacific Time.
Interested parties can access the live audio webcast for this
conference from the Investor Relations section of the company’s
website at www.immunome.com. The webcast replay will be available
after the conclusion of the live presentation for approximately 30
days.
About Immunome, Inc.
Immunome is a biotechnology company dedicated to developing
first-in-class and best-in-class targeted cancer therapies. Our
portfolio pursues each target with a modality appropriate to its
biology, including small molecules, ADCs, and radioligand
therapies. We believe that pursuing underexplored targets with
appropriate drug modalities leads to transformative therapies. Our
proprietary memory B cell hybridoma technology allows for the rapid
screening and functional characterization of novel antibodies and
targets.
For more information, visit www.immunome.com or follow us on
Twitter and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240508531812/en/
Investor Contact Max Rosett Interim Chief Financial
Officer investors@immunome.com
Immunome (NASDAQ:IMNM)
過去 株価チャート
から 5 2024 まで 6 2024
Immunome (NASDAQ:IMNM)
過去 株価チャート
から 6 2023 まで 6 2024